Using mode of action information to improve regulatory decision-making: An ECETOC/ILSI RF/HESI workshop overview
暂无分享,去创建一个
Alan R. Boobis | M. E. (Bette) Meek | Carolyn Vickers | Michelle Embry | Helmut Greim | Richard W. Lewis | Samuel M. Cohen | A. Boobis | H. Greim | M. Embry | Claudia Fruijtier-Pölloth | J. Doe | M. Bausen | N. Carmichael | C. Vickers | John Doe | Neil Carmichael | Melanie Bausen | Claudia Fruijtier-Pölloth | Richard Lewis | M.E. (Bette) Meek | Howard Mellor | S. Cohen | Howard Mellor
[1] R. Maronpot,et al. The Orphan Nuclear Receptor Constitutive Active/Androstane Receptor Is Essential for Liver Tumor Promotion by Phenobarbital in Mice , 2004, Cancer Research.
[2] Formaldehyde, 2-butoxyethanol and 1-tert-butoxypropan-2-ol. , 2006, IARC monographs on the evaluation of carcinogenic risks to humans.
[3] Ken Lunn,et al. Managing the Process , 2003 .
[4] R. L. Carter,et al. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans , 1980, IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans.
[5] Stephen W. Edwards,et al. Systems biology and mode of action based risk assessment. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.
[6] P. Calow,et al. Scientific Committee on Health and Environmental Risks opinion on: Risk Assessment Report on Vinyl acetate, Human Health Part , 2008 .
[7] Vicki L Dellarco,et al. A risk assessment perspective: application of mode of action and human relevance frameworks to the analysis of rodent tumor data. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[8] Gary M Williams,et al. Application of mode-of-action considerations in human cancer risk assessment. , 2008, Toxicology letters.
[9] E. Somers. International Agency for Research on Cancer. , 1985, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[10] E. Lock,et al. Tissue distribution of 2-(2-nitro-4-trifluoromethylbenzoyl)cyclohexane-1-3-dione (NTBC): effect on enzymes involved in tyrosine catabolism and relevance to ocular toxicity in the rat. , 1996, Toxicology and applied pharmacology.
[11] J. Haines,et al. International programme on chemical safety , 1996, The Lancet.
[12] D Hattis,et al. A preliminary operational classification system for nonmutagenic modes of action for carcinogenesis. , 2009, Critical reviews in toxicology.
[13] J. Swenberg,et al. Distribution of DNA adducts caused by inhaled formaldehyde is consistent with induction of nasal carcinoma but not leukemia. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.
[14] John C Lipscomb,et al. Mode of action as a determining factor in additivity models for chemical mixture risk assessment. , 2007, Regulatory toxicology and pharmacology : RTP.
[15] A. Boobis,et al. The Key Events Dose-Response Framework: A Cross-Disciplinary Mode-of-Action Based Approach to Examining Dose-Response and Thresholds , 2009, Critical reviews in food science and nutrition.
[17] H. Bartsch,et al. International Agency for Research on Cancer. , 1969, WHO chronicle.
[18] Jennifer Seed,et al. A Framework for Human Relevance Analysis of Information on Carcinogenic Modes of Action , 2003, Critical reviews in toxicology.
[19] Hoffmann Michael,et al. Institute for Health and Consumer Protection Activity Report 2003 , 2004 .
[20] D. Solís. US Food and Drug Administration , 2010 .
[21] J. Abraham. The international conference on harmonisation of technical requirements for registration of pharmaceuticals for human use , 2009 .
[22] A. B. Hill. The Environment and Disease: Association or Causation? , 1965, Proceedings of the Royal Society of Medicine.
[23] M. Johnson,et al. A phosphorylation site in brain and the delayed neurotoxic effect of some organophosphorus compounds. , 1969, The Biochemical journal.
[24] Division on Earth. Risk Assessment in the Federal Government: Managing the Process , 1983 .
[25] Frances E. Zollers,et al. The European Food Safety Authority: Towards coherence in food safety policy and practice , 2004 .
[26] Hyung-Sik Kang,et al. Evaluation of toxicological monitoring markers using proteomic analysis in rats exposed to formaldehyde. , 2006, Journal of proteome research.
[27] J. Verhey,et al. Risk assessment in the federal government , 1983 .
[28] Jennifer Seed,et al. Overview: Using Mode of Action and Life Stage Information to Evaluate the Human Relevance of Animal Toxicity Data , 2005, Critical reviews in toxicology.
[29] C. Wolf,et al. Human constitutive androstane receptor (CAR) and pregnane X receptor (PXR) support the hypertrophic but not the hyperplastic response to the murine nongenotoxic hepatocarcinogens phenobarbital and chlordane in vivo. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.
[30] J. G. Hengstler,et al. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH) , 2008, Archives of Toxicology.
[31] Carolyn Vickers,et al. IPCS framework for analysing the relevance of a cancer mode of action for humans , 2006 .
[32] Patricia A Stewart,et al. Mortality from lymphohematopoietic malignancies among workers in formaldehyde industries: the National Cancer Institute Cohort. , 2009, Journal of the National Cancer Institute.
[33] Shelly Puleo. US Environmental Protection Agency , 1982 .
[34] S. Eksborg,et al. Pharmacokinetics and pharmacodynamics of NTBC (2-(2-nitro-4-fluoromethylbenzoyl)-1,3-cyclohexanedione) and mesotrione, inhibitors of 4-hydroxyphenyl pyruvate dioxygenase (HPPD) following a single dose to healthy male volunteers. , 2001, British journal of clinical pharmacology.
[35] S. Hecht,et al. Clear differences in levels of a formaldehyde-DNA adduct in leukocytes of smokers and nonsmokers. , 2009, Cancer research.
[36] Alan R. Boobis,et al. IPCS Framework for Analyzing the Relevance of a Noncancer Mode of Action for Humans , 2008, Critical reviews in toxicology.
[37] B. Butterworth,et al. A classification framework and practical guidance for establishing a mode of action for chemical carcinogens. , 2006, Regulatory toxicology and pharmacology : RTP.
[38] E. Lock,et al. The role of mode of action studies in extrapolating to human risks in toxicology. , 2003, Toxicology Letters.
[39] T. Carreón-Valencia. Formaldehyde exposure and leukemia : a new meta-analysis and potential mechanisms , 2022 .
[40] M Younes,et al. IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. , 2001, Regulatory toxicology and pharmacology : RTP.
[41] Marco Vighi,et al. Scientific Committee on Health and Environmental Risks opinion on: Risk Assessment Report on 1,3,4,6,7,8-HEXAHYDRO-4,6,6,7,8,8-HEXAMETHYLCYCLOPENTA-γ-2-BENZOPYRAN (HHCB), Human Health Part, CAS No: 1222-05-5 EINECS No: 214-946-9 , 2008 .
[42] B. Meek,et al. Mode of Action Frameworks in Toxicity Testing and Chemical Risk Assessment , 2009 .
[43] Mitchell S. Wilbanks,et al. EUROPEAN CENTRE FOR ECOTOXICOLOGY AND TOXICOLOGY OF CHEMICALS , 2005 .
[44] A. Elhajouji,et al. Inhalation of formaldehyde does not induce systemic genotoxic effects in rats. , 2009, Mutation research.